September 28, 2009 β Data supporting the long-term safety and effectiveness of renal sympathetic denervation (RDN) using radio-frequency ablation in treating patients with chronic hypertension were presented Sept. 25 at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco.
September 29, 2009 - Positron Corp., a molecular imaging solutions company focused on nuclear cardiology, will attend the 14th Annual American Society of Nuclear Cardiology (ASNC) annual conference in Minneapolis, Minn. Oct. 1-4, to showcase their newly developed cardiac optimized PET scanner, the Attrius.
September 28, 2009 - GE Healthcare and Biosense Webster Inc. announced new versions of the Vivid i and Vivid q cardiovascular ultrasound systems, with support for two new intracardiac echo (ICE) catheters.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 28, 2009 - The Agency for Healthcare Research and Quality plans to provide $100 million in stimulus funding in the coming fiscal year to support studies of the effectiveness of treatments and diagnostics, including personalized healthcare approaches, such as pharmacogenetics, clinical diagnostics, and bio-imaging studies.
September 23, 2009 - After offering an amendment to close the in-office ancillary services exception for advanced medical imaging under the Stark law during the House Energy and Commerce Committeeβs continued markup of H.R. 3200, Americaβs Affordable Health Choices Act of 2009, Rep. Anthony Weiner (D-NY) and Rep. Bruce Braley (D-IA) withdrew the offer.
September 22, 2009 β At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting Royal Philips Electronics today announced it will integrate the MAQUET Magnus surgical table with Philipsβ cardiovascular X-ray systems to create an efficient hybrid operating room environment for a full range of minimally-invasive and open surgical procedures.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 23, 2009 β Abiomed Inc. announced new clinical data from USpella, the first U.S. multicenter registry of Impella 2.5 patients evaluating the safety and feasibility of left ventricular support with the Impella 2.5 during high-risk percutaneous coronary intervention (PCI) and treatment of acute myocardial infarction (AMI).
P3T products automate protocol personalization and consistently enable improved contrast enhancement for higher quality images for CT angiography and abdominal studies. P3T Cardiac enhances CT angiography of cardiac structures, coronary arteries, chambers of the heart, thoracic and abdominal aorta, and pulmonary vasculature for pulmonary embolism (PE) studies.
September 23, 2009 β To improve the ability of physicians to provide superior patient care during interventional procedures, Toshiba America Medical Systems, Inc. has introduced its Next Generation CV-3D workstation and software package available on the Infinix-i X-ray product line.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 22, 2009 β Physicians can now navigate even the most tortuous anatomy with greater speed and safety with the next-generation inferior vena cava (IVC) filter delivery system introduced today by Cook Medical at TCT 2009.
September 21, 2009 β Edwards Lifesciences Corp. today announced new clinical data demonstrating 100 percent freedom from structural deterioration of the Edwards SAPIEN valve at 18 months, as well as positive midterm patient outcomes resulting from the application of learnings from earlier clinical programs.
September 21, 2009 β Boston Scientific Corp. today welcomed three-year results from the SPIRIT III clinical trial, which continue to reaffirm the proven long-term safety of the Company's portfolio of drug-eluting stents, including the first-generation TAXUS Express(2) Paclitaxel-Eluting Coronary Stent System and the XIENCE V (PROMUS ) Everolimus-Eluting Coronary Stent
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 21, 2009 β Anticipating a change in the practice of interventional cardiology, Medtronic Inc.
September 22, 2009 β Cordis Corp. has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER Sirolimus-Eluting Coronary Stent β the 2.25 mm CYPHER β which is indicated for treatment of coronary blockages in small vessels.
September 22, 2009 β Toshiba America Medical Systems Inc. yesterday introduced Low-Contrast Imaging (LCI) for Toshibaβs Infinix-i systems with mid (12β x 12β) and large (12β x 16β) flat-panel detectors (FPD).